Wuyuan Lu

1.4k citations
30 papers · 1.1k indexed · h-index 18
Topics
Cancer-related Molecular Pathways (7 papers)Peptidase Inhibition and Analysis (6 papers)HIV Research and Treatment (5 papers)

In The Last Decade

Wuyuan Lu

29 papers receiving 1.1k citations

Peers

Wuyuan Lu
Comparison fields: 5 of 96
  • Molecular Biology 611
  • Immunology 295
  • Oncology 281
  • Microbiology 213
  • Organic Chemistry 150
Replace Weirong Yuan with:
Weirong Yuan United States
Michel Kaczorek France
Frederico Aires‐da‐Silva Portugal
Balasubramanyam Karanam United States
Haruo Takaku Japan
Edelmira Cabezas United States
Hua-Poo Su United States
Volker Gnau Germany
Tomoko Hirama Canada
Peter A. Wells United States
Wuyuan Lu relative to Weirong Yuan United States Weirong Yuan's profile →
Citations per field
00.5×1.5×
Weirong Yuan · 1×
Citations per year

Countries citing papers authored by Wuyuan Lu

Since Specialization
Citations

This map shows the geographic impact of Wuyuan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wuyuan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wuyuan Lu more than expected).

Fields of papers citing papers by Wuyuan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wuyuan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wuyuan Lu. The network helps show where Wuyuan Lu may publish in the future.

Co-authorship network of co-authors of Wuyuan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Wuyuan Lu. A scholar is included among the top collaborators of Wuyuan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wuyuan Lu. Wuyuan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 59
2 9
3 51
4 17
5 76
6 13
7 13
8 21
9
The HIV-1 matrix protein p17 activates the transcription factors c-Myc and CREB in human B cells.
6
10 68
11 67
12 45
13 22
14 15
15 191
16 1
17 22
18 14
19 140
20 48

About Wuyuan Lu

Wuyuan Lu is a scholar working on Virology, Oncology and Microbiology, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), Peptidase Inhibition and Analysis (6 papers) and HIV Research and Treatment (5 papers). The work is most often cited by research in Microbiology (213 citations), Virology (112 citations) and Immunology (295 citations). Wuyuan Lu has collaborated with scholars based in United States, China and Nigeria. Frequent co-authors include J. Łubkowski, Cyril Boulègue, David M. Hoover, Joost J. Oppenheim, De Yang, Kenneth D. Tucker, Jean K. Lim, Chong Li, Stephen K. Anderson and M. Laskowski. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026